who manufactures glp-1 drugs Novo's Wegovy becomes first drug approved for MASH GLP-1 Receptor Agonist Market Size,

Clinical trials have shown that WEGOVY leads to greater weight loss compared to other treatments, including Eli Lillys ZEPBOUND , reinforcing its position as a top obesity treatment

Meanwhile, users of weight-loss therapies based on GLP-1 agonists were warned to be aware of a rare complication, pancreatitis, which can be severe

Timing with GLP-1 injections A common question is whether Replenza should be taken on the same day as your GLP-1 injection

Additionally, some individuals may experience side effects, such as nausea or digestive issues, which often require adjusting the dosage under medical supervision

Hims uses the standard FDA criteria for GLP-1s: a BMI of 30+, or 27+ if you have a related condition like diabetes or high blood pressure